LU68940A1 - - Google Patents

Info

Publication number
LU68940A1
LU68940A1 LU68940A LU68940DA LU68940A1 LU 68940 A1 LU68940 A1 LU 68940A1 LU 68940 A LU68940 A LU 68940A LU 68940D A LU68940D A LU 68940DA LU 68940 A1 LU68940 A1 LU 68940A1
Authority
LU
Luxembourg
Application number
LU68940A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU68940A1 publication Critical patent/LU68940A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/516Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of nitrogen-containing compounds to >C = O groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/743Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups having unsaturation outside the rings, e.g. humulones, lupulones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Furan Compounds (AREA)
LU68940A 1972-12-07 1973-12-05 LU68940A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5650172A GB1402035A (en) 1972-12-07 1972-12-07 Cyclopentane derivatives

Publications (1)

Publication Number Publication Date
LU68940A1 true LU68940A1 (es) 1974-02-12

Family

ID=10476784

Family Applications (1)

Application Number Title Priority Date Filing Date
LU68940A LU68940A1 (es) 1972-12-07 1973-12-05

Country Status (13)

Country Link
JP (1) JPS5024252A (es)
AU (1) AU473283B2 (es)
BE (1) BE808398A (es)
CA (1) CA1016940A (es)
CH (1) CH605725A5 (es)
DE (1) DE2360893A1 (es)
ES (1) ES421274A1 (es)
FR (1) FR2209569B1 (es)
GB (1) GB1402035A (es)
IE (1) IE38515B1 (es)
LU (1) LU68940A1 (es)
NL (1) NL7316508A (es)
ZA (1) ZA738797B (es)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994006433A1 (en) * 1992-09-21 1994-03-31 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US6403649B1 (en) 1992-09-21 2002-06-11 Allergan Sales, Inc. Non-acidic cyclopentane heptanoic acid,2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US8278353B2 (en) 2005-03-16 2012-10-02 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8524777B2 (en) 2005-03-16 2013-09-03 Allergan Inc. Enhanced bimatoprost ophthalmic solution
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0144459A1 (de) * 1983-12-09 1985-06-19 Dr. Willmar Schwabe GmbH & Co. Prostaglandine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
JPS6240987A (ja) * 1985-08-20 1987-02-21 Nippon Steel Corp レーザビーム溶接法

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994006433A1 (en) * 1992-09-21 1994-03-31 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US6403649B1 (en) 1992-09-21 2002-06-11 Allergan Sales, Inc. Non-acidic cyclopentane heptanoic acid,2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US8278353B2 (en) 2005-03-16 2012-10-02 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8299118B2 (en) 2005-03-16 2012-10-30 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8309605B2 (en) 2005-03-16 2012-11-13 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8338479B2 (en) 2005-03-16 2012-12-25 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8524777B2 (en) 2005-03-16 2013-09-03 Allergan Inc. Enhanced bimatoprost ophthalmic solution
US8586630B2 (en) 2005-03-16 2013-11-19 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8772338B2 (en) 2005-03-16 2014-07-08 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8933120B2 (en) 2005-03-16 2015-01-13 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8933127B2 (en) 2005-03-16 2015-01-13 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US9155716B2 (en) 2005-03-16 2015-10-13 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US9241918B2 (en) 2005-03-16 2016-01-26 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure
US9801891B2 (en) 2009-12-22 2017-10-31 Allergan, Inc. Compositions and methods for lowering intraocular pressure

Also Published As

Publication number Publication date
NL7316508A (es) 1974-06-11
BE808398A (fr) 1974-06-07
AU473283B2 (en) 1976-06-17
IE38515B1 (en) 1978-03-29
FR2209569A1 (es) 1974-07-05
IE38515L (en) 1974-06-07
ZA738797B (en) 1974-07-31
JPS5024252A (es) 1975-03-15
AU6279773A (en) 1975-11-27
FR2209569B1 (es) 1978-07-28
CH605725A5 (es) 1978-10-13
CA1016940A (en) 1977-09-06
DE2360893A1 (de) 1974-06-12
GB1402035A (en) 1975-08-06
ES421274A1 (es) 1976-04-16

Similar Documents

Publication Publication Date Title
DK136713C (es)
FR2212851A5 (es)
FR2184739B1 (es)
FR2209569B1 (es)
JPS4943360A (es)
JPS5525372B2 (es)
JPS527464Y2 (es)
JPS523942Y2 (es)
JPS4919932U (es)
CS152184B1 (es)
JPS4936134U (es)
CS152532B1 (es)
JPS4893070U (es)
JPS4885167U (es)
CS152699B1 (es)
JPS4975230A (es)
CS151664B1 (es)
CS157978B1 (es)
CS152731B1 (es)
CS152691B1 (es)
CH589681A5 (es)
CH596324A5 (es)
CH589424A5 (es)
CH559489A5 (es)
BG20645A1 (es)